Literature DB >> 4372275

Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence.

V Williams, A Gershon, P A Brunell.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4372275     DOI: 10.1093/infdis/130.6.669

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  87 in total

1.  An intradermal skin test for determination of immunity to varicella.

Authors:  E Somekh; Y Bujanover; G Tal; I Dalal; A Tanay; D Lehman
Journal:  Arch Dis Child       Date:  2001-12       Impact factor: 3.791

2.  Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections.

Authors:  A A Gershon; S P Steinberg
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

3.  Cell-mediated immunity to varicella-zoster virus measured by virus inactivation: mechanism and blocking of the reaction by specific antibody.

Authors:  A A Gershon; S P Steinberg
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

4.  Antibody to varicella-zoster virus after passive immunization against chickenpox.

Authors:  A A Gershon; S Piomelli; M Karpatkin; E Smithwick; S Steinberg
Journal:  J Clin Microbiol       Date:  1978-12       Impact factor: 5.948

5.  Antibody assays for varicella-zoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation.

Authors:  B Forghani; N J Schmidt; J Dennis
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

6.  Measurement of antibodies to varicella-zoster virus by using a latex agglutination test.

Authors:  S P Steinberg; A A Gershon
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

Review 7.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

8.  Human polymorphonuclear leukocyte-mediated cytotoxicity against varicella-zoster virus-infected fibroblasts.

Authors:  T Ihara; S E Starr; M Ito; S D Douglas; A M Arbeter
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

Review 9.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

10.  COMMENTARY: Significantly less anti-gC antibody detectable in sera collected after varicella vaccination than after the disease varicella.

Authors:  Charles Grose; Young Juhn
Journal:  Pediatr Infect Dis J       Date:  2012-11       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.